Correlates of broadly neutralizing antibody development

被引:9
作者
Abela, Irene A. [1 ]
Kadelka, Claus [2 ]
Trkola, Alexandra [1 ]
机构
[1] Univ Zurich, Inst Med Virol, Winterthurerstr 190, CH-8057 Zurich, Switzerland
[2] Iowa State Univ, Dept Math, Ames, IA USA
基金
瑞士国家科学基金会;
关键词
broadly neutralizing antibodies; HIV-1; vaccine; IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1; ANTIBODY; SPONTANEOUS CONTROLLERS; HUMORAL IMMUNITY; PASSIVE TRANSFER; INFECTION; BREADTH; RESPONSES; PROTECTION; PLASMA;
D O I
10.1097/COH.0000000000000552
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review Broadly neutralizi"ng antibodies (bnAbs) are considered a key component of an effective HIV-1 vaccine, but despite intensive efforts, induction of bnAbs by vaccination has thus far not been possible. Potent bnAb activity is rare in natural infection and a deeper understanding of factors that promote or limit bnAb evolution is critical to guide bnAb vaccine development. This review reflects on recent key discoveries on correlates of bnAb development and discusses what further insights are needed to move forward. Recent findings An increasing number of parameters have been implicated to influence bnAb development in natural infection. Most recent findings highlight a range of immune factors linked with bnAb evolution. Novel approaches have brought exciting progress in defining signatures of the viral envelope associated with bnAb activity. Summary Focused efforts of recent years have unraveled a multiply layered process of HIV-1 bnAb development. As it is understood today, bnAb evolution can be triggered and influenced by a range of factors and several different pathways may exist how bnAb induction and maturation can occur. To capitalize on the gained knowledge, future research needs to validate factors to identify independent drivers of bnAb induction to advance vaccine design.
引用
收藏
页码:279 / 285
页数:7
相关论文
共 50 条
[41]   Determination of the frequency of individuals with broadly cross-reactive neutralizing antibodies against PRRSV in the sow population under field conditions [J].
Plaza-Soriano, Angeles ;
Martinez-Lobo, Francisco Javier ;
Garza-Moreno, Laura ;
Castillo-Perez, Jaime ;
Caballero, Elki ;
Castro, Jose Maria ;
Simarro, Isabel ;
Prieto, Cinta .
PORCINE HEALTH MANAGEMENT, 2024, 10 (01)
[42]   Peptide Paratope Mimics of the Broadly Neutralizing HIV-1 Antibody b12 [J].
Haussner, Christina ;
Damm, Dominik ;
Nirschl, Sandra ;
Rohrhofer, Anette ;
Schmidt, Barbara ;
Eichler, Jutta .
CHEMBIOCHEM, 2017, 18 (07) :647-653
[43]   Broadly Neutralizing Antibodies for HIV Eradication [J].
Kathryn E. Stephenson ;
Dan H. Barouch .
Current HIV/AIDS Reports, 2016, 13 :31-37
[44]   Divide and conquer: broadly neutralizing antibody combinations for improved HIV-1 viral coverage [J].
Wagh, Kshitij ;
Seaman, Michael S. .
CURRENT OPINION IN HIV AND AIDS, 2023, 18 (04) :164-170
[45]   Delivery platforms for broadly neutralizing antibodies [J].
Joshi, Lok R. ;
Galvez, Nicolas M. S. ;
Ghosh, Sukanya ;
Weiner, David B. ;
Balazs, Alejandro B. .
CURRENT OPINION IN HIV AND AIDS, 2023, 18 (04) :191-208
[46]   Broadly Neutralizing Antibodies for HIV Eradication [J].
Stephenson, Kathryn E. ;
Barouch, Dan H. .
CURRENT HIV/AIDS REPORTS, 2016, 13 (01) :31-37
[47]   Structural Basis for Penetration of the Glycan Shield of Hepatitis C Virus E2 Glycoprotein by a Broadly Neutralizing Human Antibody [J].
Li, Yili ;
Pierce, Brian G. ;
Wang, Qian ;
Keck, Zhen-Yong ;
Fuerst, Thomas R. ;
Foung, Steven K. H. ;
Mariuzza, Roy A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (16) :10117-10125
[48]   Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settings [J].
Dugdale, Caitlin M. ;
Ufio, Ogochukwu ;
Alba, Christopher ;
Permar, Sallie R. ;
Stranix-Chibanda, Lynda ;
Cunningham, Coleen K. ;
Fouda, Genevieve G. ;
Myer, Landon ;
Weinstein, Milton C. ;
Leroy, Valeriane ;
McFarland, Elizabeth J. ;
Freedberg, Kenneth A. ;
Ciaranello, Andrea L. .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2023, 26 (01)
[49]   Identification of a novel broadly HIV-1-neutralizing antibody from a CRFO1_AE- infected Chinese donor [J].
Ju, Bin ;
Li, Dan ;
Ren, Li ;
Hou, Jiali ;
Hao, Yanling ;
Liang, Hua ;
Wang, Shuo ;
Zhu, Jiang ;
Wei, Min ;
Shao, Yiming .
EMERGING MICROBES & INFECTIONS, 2018, 7
[50]   Structural Features of Broadly Neutralizing Antibodies and Rational Design of Vaccine [J].
Zhou, Tongqing ;
Xu, Kai .
HIV VACCINES AND CURE: THE PATH TOWARDS FINDING AN EFFECTIVE CURE AND VACCINE, 2018, 1075 :73-95